Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsBeneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseAre cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned ratsA Tet-on system for DRD1-expressing cellsCell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy.A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaActivation of Protein Kinases and Phosphatases Coupled to Glutamate Receptors Regulates the Phosphorylation State of DARPP32 at Threonine 75 After Repeated Exposure to Cocaine in the Rat Dorsal Striatum in a Ca2+-Dependent MannerDynamic DNA Methylation Regulates Levodopa-Induced DyskinesiaL-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.The role of dopamine receptors in the neurotoxicity of methamphetamine.Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?G protein-coupled receptor kinases as regulators of dopamine receptor functions.Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders.α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.Ras-ERK Signaling in Behavior: Old Questions and New Perspectives.Methamphetamine and Parkinson's disease.A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease.Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice.Striatal signaling: two decades of progress.Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release.Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys.Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.Levodopa treatment and dendritic spine pathology.Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum.L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.Reversing dopaminergic sensitization.Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice.Impulsive and compulsive behaviors in Parkinson's diseaseGenetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
P2860
Q21129423-A853C6EA-373B-4058-8266-F5EFAD955A59Q21131066-AFD2A13A-111C-4F4F-9B37-4668781379DBQ27324133-99FC5D14-8029-4188-914D-55FC93B077F7Q28482094-DFAE521D-B9C8-43A6-94B7-C2D07D844384Q28535290-2CEFC766-6467-4A97-99FF-EF3469B4DC02Q30650489-A8BF7AC5-614A-4F60-BE82-FA84355ADDA0Q30836713-E1134DB3-7DEE-4567-A1BD-7A3410367C34Q35324207-811EE0CF-A843-406B-87B8-CC9DD155FD4AQ35777273-A7C947BA-0638-4099-8E22-612E1F8E4818Q36363830-3CB57B1A-8AA7-4403-B581-3BDA9B461977Q37241754-12624E0E-5C96-4E90-AF49-6F3BDEBCB689Q37344222-98304350-F5A7-4346-BF04-E94AF790B64AQ38100197-2C70B389-3C80-4BC2-B5FB-FDADBF13940AQ38207680-29E9E997-6BCC-44D9-84CE-A1B9E6E5A667Q38766091-FC31E4A9-EBE1-46E4-B2E2-F74588733FB7Q38834292-5BEFAD32-C8C1-4805-AD17-81565248BA55Q38931640-AFE81CB0-9F54-461C-A847-4935DF66A3C3Q38937893-432C62D3-DBB9-4CDE-A7CC-6B2398483EA4Q39067400-94D5902E-E335-4E0C-B781-9D85A931DFA1Q39279185-87D1B0A6-7E64-4A59-9296-78916B48F434Q39348706-5EAAE74E-00C6-4A7A-AE7C-59C3F7D0F3EBQ41860851-59E40DA2-1505-4A27-8CB4-F9F0A976920DQ41967371-982B2823-5E44-4C65-921F-8EDCC23E580EQ42043545-CBA477E3-5ACA-4606-8D4F-3BF9F70D9033Q42111195-598A8CC4-5DCF-41D1-B21B-E1041E3AE848Q42512289-94BBE916-60B6-4C18-BE14-500E159B8FBFQ42640556-35AF95DD-E693-4F58-9958-B37D3C0CBBD8Q44639804-7A00ED2A-7EC4-46D1-A4B3-E48C98878936Q47637177-AD36EEF8-C5B0-4BAF-A696-11B22E5CFB92Q48113066-3990C1D7-A663-47C6-99DD-8D9E47769A87Q48280361-7AAF4334-9039-4838-BDFD-8CA9E075879FQ48843863-1F9C9A36-0EFC-4AC2-AD62-9719A04399E9Q49907939-E7C36C90-7AEF-4249-AB94-628E095EE695Q53642390-5D3D9CA9-8C43-4F35-9065-CD5229C06C74Q58492844-26170359-0780-407B-93C6-A34B0E035FB8Q58603118-DBC4D437-659B-4E9F-8A09-1D8B6E9AB86C
P2860
Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation.
@en
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation.
@nl
type
label
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation.
@en
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation.
@nl
prefLabel
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation.
@en
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation.
@nl
P2860
P921
P356
P1476
Striatal Signaling in L-DOPA-I ...... Dopamine Receptor Stimulation
@en
P2093
Mario Gustavo Murer
P2860
P356
10.3389/FNANA.2011.00051
P577
2011-08-11T00:00:00Z